Meningitis B Outbreak in Kent: Symptoms, Vaccine, and Latest Updates

A concerning outbreak of meningitis B in Kent, England, has prompted urgent health measures, including mass antibiotic distribution and vaccination campaigns. As of March 19, 2026, the outbreak has tragically resulted in two deaths and has affected at least 27 individuals, raising alarm among students and the wider community. This article provides a comprehensive overview of meningitis B, its symptoms, the current outbreak, and preventative measures.

What is Meningitis B?

Meningitis is an infection of the protective membranes surrounding the brain and spinal cord. Meningitis B (MenB), caused by the Neisseria meningitidis bacteria, is the most common form of invasive meningococcal disease in the UK. The bacteria typically resides harmlessly in the throat, but can become life-threatening if it enters the bloodstream or spinal fluid. MenB accounts for the majority of meningococcal disease cases in the UK.

Symptoms of Meningitis B

Meningitis B can progress rapidly, making early detection crucial. Symptoms can include:

• Sudden high fever
• Stiff neck
• Severe and worsening headache
• A rash that does not fade when pressed with a glass
• Aversion to bright lights
• Vomiting and diarrhoea
• Seizures
• Joint and muscle pain
• Delirium
• Extreme sleepiness

It’s important to note that early symptoms may not always be present.

The Kent Outbreak: What We Know

As of mid-March 2026, an outbreak of meningitis B has been identified in Kent, England. Two young people have died, and 27 cases have been confirmed or are suspected. The outbreak appears to be linked to events at Club Chemistry in Canterbury, with cases also identified at Canterbury Christ Church University and Escape Studios in London.

Health officials are proactively managing the situation, offering preventative antibiotic treatment to individuals who visited Club Chemistry on March 5, 6, or 7, and are rolling out a targeted vaccination drive for students at the University of Kent.

Is There a Vaccine for Meningitis B?

Yes, a vaccine for Meningitis B is available and is being utilized in the current outbreak response. The MenB vaccine is being offered to those potentially exposed as a precautionary measure. In the most recent full year, 2024-2025, there were 378 cases of invasive meningococcal disease in England.

How Serious is Meningitis B?

Meningitis B can be fatal. The infection can lead to inflammation of the brain lining and septicaemia, potentially causing sepsis. Whereas most individuals who receive early antibiotic treatment craft a full recovery, approximately one in ten infected people die. Survivors may experience long-term complications, including hearing loss, amputation, epilepsy, or learning disabilities.

Key Takeaways

• Meningitis B is a serious bacterial infection that can be life-threatening.
• Early detection and treatment with antibiotics are crucial for a positive outcome.
• A current outbreak in Kent, England, has resulted in fatalities and prompted public health interventions.
• Vaccination is available and is being used to protect those at risk.